CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Reckitt Benckiser Pharmaceuticals, Inc. v. BioDelivery Sciences International, Inc.

5:13-cv-00760

Overview

Case Number 5:13-cv-00760
Filing Date 2013-10-29
Status Terminated
Termination Date 2014-05-21
Court District Court, E.D. North Carolina (nced)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 15:1126 Patent Infringement
Jury Demand None

Parties

Plaintiff

BioDelivery Sciences International, Inc. Operating Company

Represented By

5 Attorneys Listed

Lynne A. Borchers

Myers, Bigel, Sibley & Sajovec, P.A.

Tel: +1 (919) 854-1400
Fax: +1 (919) 854-1401

Myers, Bigel, Sibley & Sajovec, P.A., P.O. Box 37428

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6331
Fax: +1 (302) 984-1260

405 N. King St., 8th Floor, Wilmington, DE 19801

Lance A. Lawson

McNair Law Firm, P.A.

Tel: +1 (704) 347-1170
Fax: +1 (704) 347-4467

301 South Tryon Street, Suite 1615

Richard T. Matthews

Post Office Box 1000 (Zip 27602)

Tel: +1 (919) 981-4000
Fax: +1 (919) 981-4300

Williams Mullen, 301 Fayetteville Street, Suite 1700

Lee Carl Bromberg

McCarter & English, LLP

Tel: +1 (617) 449-6538
Fax: +1 (617) 443-6161

265 Franklin St., Boston, MA 02110

Reckitt Benckiser Pharmaceuticals, Inc. Operating Company

Represented By

6 Attorneys Listed

Daniel A. Ladow

Troutman Sanders LLP

Tel: +1 (212) 704-6218
Fax: +1 (212) 704-5929

405 Lexington Ave., New York, NY 10538

Timothy P. Heaton

Troutman Sanders LLP

Tel: +1 (212) 704-6417
Fax: +1 (212) 704-8383

405 Lexington Ave., New York, NY 10538

Michael E. Ray

Womble Carlyle Sandridge & Rice, PLLC

Tel: +1 (336) 721-3648

One West Fourth St., Winston-Salem, NC 27101

Robert Danny Mason , Jr.

Womble Carlyle Sandridge & Rice, PLLC

Tel: +1 (336) 721-3761
Fax: +1 (336) 726-9093

One West Fourth Street, Winston-Salem, NC 27101

Gavin B. Parsons

TROUTMAN SANDERS, LLP

Tel: +1 (919) 835-4107

Post Office Drawer 1389, Raleigh, NC 27602-1389

Gary S. Parsons

Brooks Pierce Law Firm

Tel: +1 (919) 573-6241
Fax: +1 (336) 232-9040

P.O. Box 1800, Raleigh, NC 27602

Counter Defendant

MonoSol Rx, LLC Operating Company

Represented By

2 Attorneys Listed

Michael E. Ray

Womble Carlyle Sandridge & Rice, PLLC

Tel: +1 (336) 721-3648

One West Fourth St., Winston-Salem, NC 27101

Robert Danny Mason , Jr.

Womble Carlyle Sandridge & Rice, PLLC

Tel: +1 (336) 721-3761
Fax: +1 (336) 726-9093

One West Fourth Street, Winston-Salem, NC 27101

RB Pharmaceuticals Limited NPE (University / Research)

Represented By

6 Attorneys Listed

Daniel A. Ladow

Troutman Sanders LLP

Tel: +1 (212) 704-6218
Fax: +1 (212) 704-5929

405 Lexington Ave., New York, NY 10538

Timothy P. Heaton

Troutman Sanders LLP

Tel: +1 (212) 704-6417
Fax: +1 (212) 704-8383

405 Lexington Ave., New York, NY 10538

Michael E. Ray

Womble Carlyle Sandridge & Rice, PLLC

Tel: +1 (336) 721-3648

One West Fourth St., Winston-Salem, NC 27101

Robert Danny Mason , Jr.

Womble Carlyle Sandridge & Rice, PLLC

Tel: +1 (336) 721-3761
Fax: +1 (336) 726-9093

One West Fourth Street, Winston-Salem, NC 27101

Gavin B. Parsons

TROUTMAN SANDERS, LLP

Tel: +1 (919) 835-4107

Post Office Drawer 1389, Raleigh, NC 27602-1389

Gary S. Parsons

Brooks Pierce Law Firm

Tel: +1 (919) 573-6241
Fax: +1 (336) 232-9040

P.O. Box 1800, Raleigh, NC 27602

Court & Judges

Court

District Court, E.D. North Carolina (nced)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

35

Dispositive

32

Granted

2

Denied

0

Pending / Review

17

Motions by Category

Motion to Dismiss (FRCP 12(b)(6)) 9 Motion to Stay 2 Motion to Stay Pending IPR / Reexam 18 Procedural / Extension Motion 1 Motion to Dismiss 5

Key Dispositive Motions & Rulings

Motion to Dismiss Granted
ORDER GRANTING 18 Defendant's Motion to Dismiss, GRANTING 30 Motion to Seal, DENYING AS MOOT 33 Defendant's Motion to Stay, and GRANTING 42 Motion to Seal. The ...
Entry #51 • 2014-05-21 Document →
Motion to Dismiss Pending / Under Review
JUDGMENT: IT IS ORDERED, ADJUDGED, and DECREED that the defendant's Motion to Dismiss [DE 18] is hereby GRANTED. The plaintiffs' complaint is dismissed in its e...
Entry #52 • 2014-05-21 Document →
Motion to Dismiss Pending / Under Review
MINUTE ENTRY FOR PROCEEDINGS held before US District Judge Terrence W. Boyle: Motion Hearing held on 4/25/2014 in Raleigh, North Carolina, regarding 18 Defendan...
Entry #50 • 2014-04-25 Document →
Motion to Dismiss Pending / Under Review
RESPONSE regarding 48 Response in Support of Motion, Opposing Supplemental Filing in Support of Motion to Dismiss 18, filed by MonoSol Rx, LLC, RB Pharmaceutica...
Entry #49 • 2014-04-23 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
NOTICE by MonoSol Rx, LLC, RB Pharmaceuticals Limited, Reckitt Benckiser Pharmaceuticals, Inc. regarding 18 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM MOTIO...
Entry #47 • 2014-04-22 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
RESPONSE in Support regarding 18 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM MOTION to Dismiss For Lack of Subject Matter Jurisdiction, and MOTION to Dismiss...
Entry #48 • 2014-04-22 Document →

Docket Entries

(77 total)
Pleading / Complaint

COMPLAINT against All Defendants ( Filing fee $ 400 receipt number 0417-2690178.), filed by Reckitt Benckiser Pharmaceuticals, Inc., MonoSol Rx, LLC, RB Pharmaceuticals Limited. (Attachments: # 1 Exhibit A - '832 Patent, # 2 Exhibit B - 8-1-13 Press Release, # 3 Exhibit C - 8-12-13 Petition, # 4 Exhibit D - Open Label Study, # 5 Exhibit E - 9-18-13 FDA Petition Response, # 6 Exhibit F - 2012 Annual Report, # 7 Exhibit G - 8-9-13 Press Release, # 8 Exhibit H - 10-9-13 Press Release) (Ray, Michael) (Entered: 10/29/2013)

Entry #1 • 2013-10-29
1
Pleading / Complaint

COMPLAINT against All Defendants ( Filing fee $ 400 receipt number 0417-2690178.), filed by Reckitt Benckiser Pharmaceuticals, Inc., MonoSol Rx, LLC, RB Pharmaceuticals Limited. (Attachments: # 1 Exhibit A - '832 Patent, # 2 Exhibit B - 8-1-13 Press Release, # 3 Exhibit C - 8-12-13 Petition, # 4 Exhibit D - Open Label Study, # 5 Exhibit E - 9-18-13 FDA Petition Response, # 6 Exhibit F - 2012 Annual Report, # 7 Exhibit G - 8-9-13 Press Release, # 8 Exhibit H - 10-9-13 Press Release) (Ray, Michael) (Entered: 10/29/2013)

Entry #1 • 2013-10-29
2
Pleading / Complaint

COMPLAINT against All Defendants ( Filing fee $ 400 receipt number 0417-2690178.), filed by Reckitt Benckiser Pharmaceuticals, Inc., MonoSol Rx, LLC, RB Pharmaceuticals Limited. (Attachments: # 1 Exhibit A - '832 Patent, # 2 Exhibit B - 8-1-13 Press Release, # 3 Exhibit C - 8-12-13 Petition, # 4 Exhibit D - Open Label Study, # 5 Exhibit E - 9-18-13 FDA Petition Response, # 6 Exhibit F - 2012 Annual Report, # 7 Exhibit G - 8-9-13 Press Release, # 8 Exhibit H - 10-9-13 Press Release) (Ray, Michael) (Entered: 10/29/2013)

Entry #1 • 2013-10-29
2
Pleading / Complaint

COMPLAINT against All Defendants ( Filing fee $ 400 receipt number 0417-2690178.), filed by Reckitt Benckiser Pharmaceuticals, Inc., MonoSol Rx, LLC, RB Pharmaceuticals Limited. (Attachments: # 1 Exhibit A - '832 Patent, # 2 Exhibit B - 8-1-13 Press Release, # 3 Exhibit C - 8-12-13 Petition, # 4 Exhibit D - Open Label Study, # 5 Exhibit E - 9-18-13 FDA Petition Response, # 6 Exhibit F - 2012 Annual Report, # 7 Exhibit G - 8-9-13 Press Release, # 8 Exhibit H - 10-9-13 Press Release) (Ray, Michael) (Entered: 10/29/2013)

Entry #1 • 2013-10-29
2
Pleading / Complaint

COMPLAINT against All Defendants ( Filing fee $ 400 receipt number 0417-2690178.), filed by Reckitt Benckiser Pharmaceuticals, Inc., MonoSol Rx, LLC, RB Pharmaceuticals Limited. (Attachments: # 1 Exhibit A - '832 Patent, # 2 Exhibit B - 8-1-13 Press Release, # 3 Exhibit C - 8-12-13 Petition, # 4 Exhibit D - Open Label Study, # 5 Exhibit E - 9-18-13 FDA Petition Response, # 6 Exhibit F - 2012 Annual Report, # 7 Exhibit G - 8-9-13 Press Release, # 8 Exhibit H - 10-9-13 Press Release) (Ray, Michael) (Entered: 10/29/2013)

Entry #1 • 2013-10-29
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc